Added to YB: 2021-02-22
Pitch date: 2021-02-22
ONCR:US [bullish]
Oncorus, Inc.
-99.31%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients.
Market Cap
$3.3M
Pitch Price
$18.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.46
P/E
-0.04
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Oncorus, Inc. ONCR:US
A summary for this pitch has not been created yet.
Read full article (0 min)